Latest F-1 registration statements

Oncolytics Biotech Inc. has filed a post-effective amendment to deregister unsold securities from multiple previous F-10 registration statements.

Oncolytics Biotech Inc. is filing post-effective amendments to deregister unsold securities from multiple previous registration statements.

Oncolytics Biotech files post-effective amendments to deregister unsold securities from multiple prior registration statements.

Oncolytics Biotech files post-effective amendments to deregister unsold securities from multiple prior registration statements.

Oncolytics Biotech Inc. has filed a post-effective amendment to deregister unsold securities from multiple previous registration statements.

Oncolytics Biotech Inc. has filed a post-effective amendment to deregister unsold securities from multiple previous F-10 registration statements.

Oncolytics Biotech Inc. has filed a post-effective amendment to deregister unsold securities from multiple previous F-10 registration statements.

CSC Collective Holdings Limited, a Hong Kong-based luxury restaurant operator, has filed an amended F-1 registration statement with the SEC for its proposed initial public offering.

Oncolytics Biotech Inc. files a post-effective amendment to deregister unsold securities from multiple previous F-10 registration statements.

Oncolytics Biotech files post-effective amendment to deregister unsold securities from multiple prior F-10 registration statements.

Oncolytics Biotech Inc. is filing a post-effective amendment to deregister unsold securities from multiple previous F-10 registration statements.

Oncolytics Biotech Inc. files a post-effective amendment to deregister unsold securities from multiple previous F-10 registration statements, updating the effectiveness date for remaining registrations.

Oncolytics Biotech files post-effective amendment to deregister unsold securities from multiple prior registration statements.

Oncolytics Biotech files post-effective amendment to deregister unsold securities from multiple prior registration statements.

Oncolytics Biotech files post-effective amendment to deregister unsold securities from multiple prior F-10 registration statements.

Oncolytics Biotech Inc. has filed a post-effective amendment to multiple registration statements to revise the effectiveness date for the deregistration of unsold securities.

Oncolytics Biotech Inc. has filed a post-effective amendment to its F-10 registration statements to revise the effectiveness date for the deregistration of unsold securities.

Oncolytics Biotech files post-effective amendment to withdraw unsold securities from multiple prior registration statements, revising effectiveness date for remaining registrations.

Libera Gaming Operations, Inc. has filed a pre-effective amendment to its Form F-1 registration statement with the SEC, outlining plans for an initial public offering of 3,750,000 common shares on the Nasdaq under the symbol LBRJ.

DCR Tech Group Ltd has filed an F-1/A amendment with the SEC, detailing its initial public offering of 5,000,000 Class A Ordinary Shares.

The Magnum Ice Cream Company N.V. has filed a registration statement for the potential resale of up to 121.6 million ordinary shares by Unilever.

Brookfield Business Corporation has filed a Form F-10 registration statement to offer up to $1.5 billion in securities, including Class A shares, preferred shares, and subscription receipts.

IceCure Medical Ltd. has filed an F-1 registration statement for the resale of up to 16 million ordinary shares by selling shareholders, stemming from recent warrant issuances.

FG Holdings Limited, a Hong Kong-based financial services provider, is offering 3.75 million Class A Ordinary Shares at $4.00 each, seeking a Nasdaq Capital Market listing to fund strategic growth initiatives.

Oncolytics Biotech Inc. filed a post-effective amendment to deregister unsold portions of securities from multiple previous shelf registration statements.

Oncolytics Biotech Inc. has filed post-effective amendments to withdraw multiple Form F-10 registration statements for unsold securities.

Oncolytics Biotech Inc. has filed post-effective amendments to withdraw unsold portions of securities from multiple previous F-10 registration statements.

Oncolytics Biotech Inc. has filed post-effective amendments to withdraw multiple Form F-10 registration statements for unsold securities.

Oncolytics Biotech Inc. has filed post-effective amendments to withdraw multiple Form F-10 registration statements, deregistering unsold portions of various securities.

Oncolytics Biotech Inc. has filed post-effective amendments to deregister unsold portions of securities from multiple previous registration statements.